ProCE Banner Activity

Therapeutic Advances in Relapsed/Refractory DLBCL: Improving Outcomes with Novel Approaches to Targeted Therapy


Download these slides on therapeutic approaches to managing patients with relapsed/refractory diffuse large B-cell lymphoma.

Released: November 08, 2023



John N. Allan

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

John M. Burke

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

Provided by

Jointly provided by USF Health and Rockpointe.

ProCE Banner
ProCE Banner


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc